Cancer Stories
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
A 53-year-old woman presented in July 2022 with large pelvic masses. Surgery included hysterectomy, removal of both ovaries and fallopian tubes, omentectomy, appendectomy and pelvic lymph-node sampling. Pathology showed high-grade serous carcinoma involving both ovaries, with no cancer found in the sampled pelvic lymph nodes. Her cancer was classified as Stage II. Somatic BRCA1/2 testing was negative.
She started carboplatin plus paclitaxel chemotherapy. After the first cycle, her liver enzymes rose sharply, and other common causes of liver injury were excluded. The care team diagnosed paclitaxel-related hepatotoxicity and treated the liver injury while monitoring her closely.
Once the liver tests improved, chemotherapy was restarted after a delay with a reduced paclitaxel dose. She tolerated the remaining treatment with manageable liver-test abnormalities and completed all six planned chemotherapy cycles. She then moved to routine surveillance.
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer